People | March 22, 2022
Trivitron Healthcare elevates Chandra Ganjoo to Group CEO
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
This has further strengthened its manufacturing presence in the United States of America
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated
